Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes

被引:33
作者
Cashin, Kieran [1 ,2 ]
Gray, Lachlan R. [1 ,3 ]
Harvey, Katherine L. [1 ,2 ]
Perez-Bercoff, Danielle [4 ]
Lee, Guinevere Q. [5 ]
Sterjovski, Jasminka [1 ,3 ]
Roche, Michael [1 ,3 ]
Demarest, James F. [6 ]
Drummond, Fraser [7 ]
Harrigan, P. Richard [5 ]
Churchill, Melissa J. [1 ,8 ,9 ]
Gorry, Paul R. [1 ,2 ,3 ,10 ]
机构
[1] Burnet Inst, Ctr Biomed Res, Melbourne, Vic 3004, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[3] Monash Univ, Dept Infect Dis, Melbourne, Vic 3800, Australia
[4] Ctr Rech Publ Sante, Lab Retrovirol, L-1526 Luxembourg, Luxembourg
[5] BC Ctr Excellence HIV AIDS, Vancouver, BC Y6Z 1Y6, Canada
[6] ViiV Healthcare, Res Triangle Pk, NC 27709 USA
[7] ViiV Healthcare Australia, Abbotsford, WA 3067, Australia
[8] Monash Univ, Dept Med, Melbourne, Vic 3800, Australia
[9] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia
[10] RMIT Univ, Coll Sci Engn & Hlth, Sch Appl Sci, Melbourne, Vic 3001, Australia
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
基金
美国国家卫生研究院; 英国医学研究理事会; 澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; CORECEPTOR USAGE PREDICTION; TREATMENT-NAIVE PATIENTS; AMINO-ACID CHANGES; VIROLOGICAL RESPONSE; EVOLVING EPIDEMIC; PHENOTYPIC ASSAY; VIRAL TROPISM; CXCR4; TROPISM; V3; LOOP;
D O I
10.1038/srep08543
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Over the past decade antiretroviral drugs have dramatically improved the prognosis for HIV-1 infected individuals, yet achieving better access to vulnerable populations remains a challenge. The principal obstacle to the CCR5-antagonist, maraviroc, from being more widely used in anti-HIV-1 therapy regimens is that the pre-treatment genotypic "tropism tests'' to determine virus susceptibility to maraviroc have been developed primarily for HIV-1 subtype B strains, which account for only 10% of infections worldwide. We therefore developed PhenoSeq, a suite of HIV-1 genotypic tropism assays that are highly sensitive and specific for establishing the tropism of HIV-1 subtypes A, B, C, D and circulating recombinant forms of subtypes AE and AG, which together account for 95% of HIV-1 infections worldwide. The PhenoSeq platform will inform the appropriate use of maraviroc and future CCR5 blocking drugs in regions of the world where non-B HIV-1 predominates, which are burdened the most by the HIV-1 pandemic.
引用
收藏
页数:8
相关论文
共 76 条
  • [1] Genetic Characteristics, Coreceptor Usage Potential and Evolution of Nigerian HIV-1 Subtype G and CRF02_AG Isolates
    Ajoge, Hannah O.
    Gordon, Michelle L.
    de Oliveira, Tulio
    Green, Taryn N.
    Ibrahim, Sani
    Shittu, Oladapo S.
    Olonitola, Stephen O.
    Ahmad, Aliyu A.
    Ndung'u, Thumbi
    [J]. PLOS ONE, 2011, 6 (03):
  • [2] [Anonymous], 2013, UNAIDS, V1, P1
  • [3] The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa
    Ataher, Quazi
    Portsmouth, Simon
    Napolitano, Laura A.
    Eng, Sybil
    Greenacre, Anna
    Kambugu, Andrew
    Wood, Robin
    Badal-Faesen, Sharlaa
    Tressler, Randy
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [4] HIV-1 coreceptor usage prediction without multiple alignments: an application of string kernels
    Boisvert, Sebastien
    Marchand, Mario
    Laviolette, Francois
    Corbeil, Jacques
    [J]. RETROVIROLOGY, 2008, 5 (1)
  • [5] Braun P, 2007, EUR J MED RES, V12, P463
  • [6] Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+ T-cell subsets, including stem cell memory T-cells
    Cashin, Kieran
    Paukovics, Geza
    Jakobsen, Martin R.
    Ostergaard, Lars
    Churchill, Melissa J.
    Gorry, Paul R.
    Flynn, Jacqueline K.
    [J]. RETROVIROLOGY, 2014, 11
  • [7] Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms
    Cashin, Kieran
    Sterjovski, Jasminka
    Harvey, Katherine L.
    Ramsland, Paul A.
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. PLOS ONE, 2014, 9 (10):
  • [8] Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
    Cashin, Kieran
    Jakobsen, Martin R.
    Sterjovski, Jasminka
    Roche, Michael
    Ellett, Anne
    Flynn, Jacqueline K.
    Borm, Katharina
    Gouillou, Maelenn
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. RETROVIROLOGY, 2013, 10
  • [9] CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm
    Cashin, Kieran
    Gray, Lachlan R.
    Jakobsen, Martin R.
    Sterjovski, Jasminka
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. RETROVIROLOGY, 2013, 10
  • [10] Alternative Coreceptor Requirements for Efficient CCR5-and CXCR4-Mediated HIV-1 Entry into Macrophages
    Cashin, Kieran
    Roche, Michael
    Sterjovski, Jasminka
    Ellett, Anne
    Gray, Lachlan R.
    Cunningham, Anthony L.
    Ramsland, Paul A.
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (20) : 10699 - 10709